Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

U Germing

Showing results (71-80 of 126) with videos related to

Pageof 13
Sort By:
Leukemia Research|December 5, 2021
The WHO 2016 diagnostic criteria for Acute Myeloid leukemia with myelodysplasia related changes (AML-MRC) produce a very heterogeneous entity: A retrospective analysis of the FAB subtype RAEB-TJ Kaivers, J Peters, C Rautenberg, et al.
Leukemia|March 3, 2012
Clonal relationship between langerhans cell histiocytosis and myeloid sarcomaA H Schmitt-Graeff, H Duerkop, B Vollmer-Kary, et al.
Diagnostic Cytopathology|November 13, 1998
Pleural carcinosis confirmed by adjuvant cytological methods: a case reportH Motherby, B Ross, M Kube, et al.
Leukemia Research|December 3, 2014
Refined medullary blast and white blood cell count based classification of chronic myelomonocytic leukemiasE Schuler, M Schroeder, J Neukirchen, et al.
Bone Marrow Transplantation|April 12, 2005
Cyclosporine A and mycophenolate mofetil vs cyclosporine A and methotrexate for graft-versus-host disease prophylaxis after stem cell transplantation from HLA-identical siblingsF Neumann, T Graef, C Tapprich, et al.
European Journal of Haematology|April 25, 2000
Acute promyelocytic leukemia and pregnancyA A Giagounidis, M W Beckmann, A S Giagounidis, et al.
Leukemia Research|December 8, 2017
Myelodysplastic syndromes without peripheral monocytosis but with evidence of marrow monocytosis share clinical and molecular characteristics with CMMLE Schuler, F Frank, B Hildebrandt, et al.
Annals of Hematology|November 18, 2005
Quantification of outpatient management and hospitalization of patients with high-risk myelodysplastic syndrome treated with low-dose decitabineJ A Pitako, P S Haas, J Van den Bosch, et al.
Leukemia & Lymphoma|June 27, 1998
Dyshematopoiesis in de novo acute myeloid leukemia: cell biological features and prognostic significanceG Meckenstock, C Aul, B Hildebrandt, et al.
Leukemia|December 22, 2012
Lenalidomide does not increase AML progression risk in RBC transfusion-dependent patients with Low- or Intermediate-1-risk MDS with del(5q): a comparative analysisA Kuendgen, M Lauseker, A F List, et al.
Pageof 13

Showing results (71-80 of 126) with videos related to

Sort By:
Pageof 13
Leukemia Research|December 5, 2021
The WHO 2016 diagnostic criteria for Acute Myeloid leukemia with myelodysplasia related changes (AML-MRC) produce a very heterogeneous entity: A retrospective analysis of the FAB subtype RAEB-TJ Kaivers, J Peters, C Rautenberg, et al.
Leukemia|March 3, 2012
Clonal relationship between langerhans cell histiocytosis and myeloid sarcomaA H Schmitt-Graeff, H Duerkop, B Vollmer-Kary, et al.
Diagnostic Cytopathology|November 13, 1998
Pleural carcinosis confirmed by adjuvant cytological methods: a case reportH Motherby, B Ross, M Kube, et al.
Leukemia Research|December 3, 2014
Refined medullary blast and white blood cell count based classification of chronic myelomonocytic leukemiasE Schuler, M Schroeder, J Neukirchen, et al.
Bone Marrow Transplantation|April 12, 2005
Cyclosporine A and mycophenolate mofetil vs cyclosporine A and methotrexate for graft-versus-host disease prophylaxis after stem cell transplantation from HLA-identical siblingsF Neumann, T Graef, C Tapprich, et al.
European Journal of Haematology|April 25, 2000
Acute promyelocytic leukemia and pregnancyA A Giagounidis, M W Beckmann, A S Giagounidis, et al.
Leukemia Research|December 8, 2017
Myelodysplastic syndromes without peripheral monocytosis but with evidence of marrow monocytosis share clinical and molecular characteristics with CMMLE Schuler, F Frank, B Hildebrandt, et al.
Annals of Hematology|November 18, 2005
Quantification of outpatient management and hospitalization of patients with high-risk myelodysplastic syndrome treated with low-dose decitabineJ A Pitako, P S Haas, J Van den Bosch, et al.
Leukemia & Lymphoma|June 27, 1998
Dyshematopoiesis in de novo acute myeloid leukemia: cell biological features and prognostic significanceG Meckenstock, C Aul, B Hildebrandt, et al.
Leukemia|December 22, 2012
Lenalidomide does not increase AML progression risk in RBC transfusion-dependent patients with Low- or Intermediate-1-risk MDS with del(5q): a comparative analysisA Kuendgen, M Lauseker, A F List, et al.
Pageof 13